Tekla Life Sciences Inves... (HQL)

NYSE: HQL · Real-Time Price · USD

12.98

0.28 (2.20%)

At close: May 02, 2025, 3:59 PM

13.01

0.19%

After-hours: May 02, 2025, 04:05 PM EDT

2.20% (1D)

Bid	12.7
Market Cap	374.91M
Revenue (ttm)	3.98M
Net Income (ttm)	85.3M
EPS (ttm)	3.04
PE Ratio (ttm)	4.27
Forward PE	n/a
Analyst	n/a

Ask	13.26
Volume	74,249
Avg. Volume (20D)	134,837
Open	12.85
Previous Close	12.70
Day's Range	12.84 - 13.03
52-Week Range	10.55 - 15.90
Beta	0.77

About HQL

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries,...

[Read more]

Industry Asset Management

Sector Financial Services

IPO Date May 1, 1992

Employees NaN

Stock Exchange NYSE

Ticker Symbol HQL

Website https://www.teklacap.com/hql.html

Full Company Profile

News

2 days ago · fool.com

These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount

My definition of a high yield is any yield at least twice the level of the S&P 500's yield. The threshold is currently around 2.56%.

1 month ago · seekingalpha.com

5 Best CEFs This Month For Yields Up To 14%

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, ...

2 months ago · seekingalpha.com

HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X